Back to Search
Start Over
Supplementary Data from Landscape of Acquired Resistance to Osimertinib in EGFR-Mutant NSCLC and Clinical Validation of Combined EGFR and RET Inhibition with Osimertinib and BLU-667 for Acquired RET Fusion
- Publication Year :
- 2023
- Publisher :
- American Association for Cancer Research (AACR), 2023.
-
Abstract
- Supplementary Data and Methods
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....dc96358440634edc76f9afcf0d045e29
- Full Text :
- https://doi.org/10.1158/2159-8290.22534325.v1